← All trials
NCT04053205
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2019
- Primary completion
- Jun 30, 2020
- Completion date
- Dec 31, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 76
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- GeneScience Pharmaceuticals Co., Ltd.Lead sponsor
- Zhengzhou UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Jilin UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Huazhong University of Science and TechnologyCollaborator
- Sun Yat-Sen UniversityCollaborator
- Zhejiang UniversityCollaborator
- Harbin Medical UniversityCollaborator
- Fujian Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.